NYSE:DHRDanaher Stock Price, Forecast & News

$167.40

+0.44 (+0.26 %)

(As of 06/3/2020 11:23 AM ET)

Add

Compare

Today's Range

$166.21

Now: $167.40▼

$168.47

50-Day Range

$145.73

MA: $160.40▼

$169.51

52-Week Range

$119.60

Now: $167.40▼

$170.64

Volume702,973 shs

Average Volume3.51 million shs

Market Capitalization$116.76 billion

P/E Ratio38.05

Dividend Yield0.44%

Beta0.91

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides equipment, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia. Cepheid, a company which is developing a faster test for COVID-19, is a subsidiary of Danaher.

Beat the Market (BTM) Rank^™

2.3 Analyst's Opinion

Consensus Rating
Danaher has received a consensus rating of Buy. The company's average rating score is 2.69, and is based on 9 buy ratings, 4 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $169.27, Danaher has a potential upside of 1.8% from its current price of $166.28.
Amount of Analyst Coverage
Danaher has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

3.1 Community Rank

Outperform Votes
Danaher has received 917 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Danaher has received 549 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Danaher has received 62.55% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Danaher and other stocks. Vote “Outperform” if you believe DHR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe DHR will underperform the S&P 500 over the long term. You may vote once every thirty days.

3.3 Dividend Strength

Dividend Leadership
Danaher is a leading dividend payer. It pays a dividend yield of 0.44%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Danaher has only been increasing its dividend for 2 years.
Dividend Coverage
The dividend payout ratio of Danaher is 16.29 %. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Danaher will have a dividend payout ratio of 12.59 % next year. This indicates that Danaher will be able to sustain or increase its dividend.

4.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Danaher insiders have bought 68.50% more of their company's stock than they have sold. Specifically, they have bought $23,490,298.00 in company stock and sold $13,941,119.00 in company stock.
Percentage Held by Insiders
Only 11.70% of the stock of Danaher is held by insiders.
Percentage Held by Institutions
77.80% of the stock of Danaher is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Danaher are expected to grow by 17.21% in the coming year, from $4.88 to $5.72 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Danaher is 37.79, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 15.94.
Price to Earnings Ratio vs. Sector
The P/E ratio of Danaher is 37.79, which means that it is trading at a more expensive P/E ratio than the Multi-Sector Conglomerates sector average P/E ratio of about 13.70.
Price to Earnings Growth Ratio
Danaher has a PEG Ratio of 3.73. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Danaher has a P/B Ratio of 4.16. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

2.68 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Process control instruments

Sub-IndustryIndustrial Conglomerates

SectorMulti-Sector Conglomerates

Current SymbolNYSE:DHR

Previous Symbol

CUSIP23585110

CIK313616

Webwww.danaher.com

Phone202-828-0850

Debt

Debt-to-Equity Ratio0.77

Current Ratio1.32

Quick Ratio1.01

Price-To-Earnings

Trailing P/E Ratio38.05

Forward P/E Ratio34.30

P/E Growth3.73

Sales & Book Value

Annual Sales$17.91 billion

Price / Sales6.52

Cash Flow$6.29 per share

Price / Cash Flow26.61

Book Value$39.93 per share

Price / Book4.19

Profitability

EPS (Most Recent Fiscal Year)$4.42

Net Income$3.01 billion

Net Margins16.85%

Return on Equity11.52%

Return on Assets5.64%

Miscellaneous

Employees60,000

Outstanding Shares697,510,000

Market Cap$116.76 billion

Next Earnings Date7/16/2020 (Estimated)

OptionableOptionable

Receive DHR News and Ratings via Email

Sign-up to receive the latest news and ratings for DHR and its competitors with MarketBeat's FREE daily newsletter.

Danaher (NYSE:DHR) Frequently Asked Questions

How has Danaher's stock been impacted by COVID-19 (Coronavirus)?

Danaher's stock was trading at $139.37 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, DHR stock has increased by 19.3% and is now trading at $166.28. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Danaher?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last year. There are currently 4 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Danaher.

When is Danaher's next earnings date?

Danaher is scheduled to release its next quarterly earnings announcement on Thursday, July 16th 2020. View our earnings forecast for Danaher.

How were Danaher's earnings last quarter?

Danaher Co. (NYSE:DHR) issued its quarterly earnings data on Wednesday, May, 6th. The conglomerate reported $1.05 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.00 by $0.05. The conglomerate earned $4.34 billion during the quarter, compared to the consensus estimate of $4.32 billion. Danaher had a net margin of 16.85% and a return on equity of 11.52%. The firm's quarterly revenue was up 2.9% compared to the same quarter last year. During the same period last year, the business posted $1.07 earnings per share. View Danaher's earnings history.

How often does Danaher pay dividends? What is the dividend yield for Danaher?

Danaher declared a quarterly dividend on Tuesday, May 5th. Investors of record on Friday, June 26th will be paid a dividend of $0.18 per share on Friday, July 31st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.43%. The ex-dividend date of this dividend is Thursday, June 25th. View Danaher's dividend history.

What guidance has Danaher issued on next quarter's earnings?

Danaher issued an update on its first quarter 2020 Pre-Market earnings guidance on Monday, April, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $5.026-5.026 billion, compared to the consensus revenue estimate of $4.28 billion.

What price target have analysts set for DHR?

13 brokers have issued 12 month price objectives for Danaher's stock. Their forecasts range from $136.00 to $190.00. On average, they expect Danaher's stock price to reach $169.27 in the next year. This suggests a possible upside of 1.8% from the stock's current price. View analysts' price targets for Danaher.

Has Danaher been receiving favorable news coverage?

Press coverage about DHR stock has been trending somewhat positive recently, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Danaher earned a coverage optimism score of 0.6 on InfoTrie's scale. They also gave news coverage about the conglomerate a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news aboutDanaher.

Are investors shorting Danaher?

Danaher saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 6,600,000 shares, an increase of 5.4% from the April 15th total of 6,260,000 shares. Based on an average daily trading volume, of 3,740,000 shares, the days-to-cover ratio is presently 1.8 days. Currently, 1.1% of the shares of the company are short sold. View Danaher's Current Options Chain.

Who are some of Danaher's key competitors?

Some companies that are related to Danaher include Roper Technologies (ROP), Fortive (FTV), Keysight Technologies (KEYS), Cognex (CGNX), Sensata Technologies (ST), MKS Instruments (MKSI), Mesa Laboratories (MLAB), Hurco Companies (HURC), Crawford United (CRAWA), Hickok (HICKA), International Isotopes (INIS), Clearsign Combustion (CLIR), Sypris Solutions (SYPR), Electro-Sensors (ELSE) and Schmitt Industries (SMIT). View all competitors.

What other stocks do shareholders of Danaher own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Danaher investors own include NVIDIA (NVDA), Home Depot (HD), Walt Disney (DIS), Cisco Systems (CSCO), Adobe (ADBE), Johnson & Johnson (JNJ), Alibaba Group (BABA), Intel (INTC), Alphabet (GOOG) and CVS Health (CVS).

Who are Danaher's key executives?

Danaher's management team includes the following people:

Mr. Thomas P. Joyce Jr., CEO, Pres & Director (Age 59)
Mr. Daniel L. Comas, Exec. VP (Age 56)
Mr. William K. Daniel II, Exec. VP (Age 55)
Mr. Rainer M. Blair, Exec. VP (Age 56)
Mr. Joakim Weidemanis, Exec. VP (Age 50)

What is Danaher's stock symbol?

Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."

Who are Danaher's major shareholders?

Danaher's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Geode Capital Management LLC (1.34%), Aristotle Capital Management LLC (1.03%), Capital International Investors (0.98%), Bank of New York Mellon Corp (0.75%), Parnassus Investments CA (0.70%) and Legal & General Group Plc (0.60%). Company insiders that own Danaher stock include Alan G Spoon, Angela S Lalor, Brian W Ellis, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King. View institutional ownership trends for Danaher.

Which institutional investors are selling Danaher stock?

DHR stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., AQR Capital Management LLC, Waddell & Reed Financial Inc., Deutsche Bank AG, Eaton Vance Management, Prudential PLC, Aviva PLC, and Caisse DE Depot ET Placement DU Quebec. Company insiders that have sold Danaher company stock in the last year include Angela S Lalor, Brian W Ellis, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, Linda P Hefner, Matthew Mcgrew, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel, and William King. View insider buying and selling activity for Danaher.

Which institutional investors are buying Danaher stock?

DHR stock was bought by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Swedbank, Capital International Investors, Swiss National Bank, Two Sigma Advisers LP, APG Asset Management N.V., APG Asset Management N.V., and Pictet Asset Management Ltd.. View insider buying and selling activity for Danaher.

How do I buy shares of Danaher?

Shares of DHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Danaher's stock price today?

One share of DHR stock can currently be purchased for approximately $166.28.

How big of a company is Danaher?

Danaher has a market capitalization of $115.98 billion and generates $17.91 billion in revenue each year. The conglomerate earns $3.01 billion in net income (profit) each year or $4.42 on an earnings per share basis. Danaher employs 60,000 workers across the globe.

What is Danaher's official website?

The official website for Danaher is www.danaher.com.

How can I contact Danaher?

Danaher's mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The conglomerate can be reached via phone at 202-828-0850 or via email at [email protected]

This page was last updated on 6/3/2020 by MarketBeat.com Staff